...seems like many here are are oblivious to or forgotten this quote below in The Astralian on Nov 4 2016...any guesstimates of the real value inherent in NTI and it's technology platform posted here on HC is seriously flawed imo...(my bold below)
"Neurotech chief executive Wolfgang Storf said the company believed there was an opportunity for the company to build a range of independently certified medical devices to target the $US169 billion ($220bn) medical neurotechnology and $US12bn medical home-based device markets.
“We start with autism but the potential is for so many additional areas, epilepsy, depression … unlimited potential,” he said."
